They feature the profile of Her Late Majesty The Queen on a plain coloured background." If you still have old stamps which don’t have a barcode on them, they can be exchanged for new barcoded ...

It’s not HBO, it’s Max — but the new standalone logo for Warner Bros. Discovery‘s streamer now certainly looks like HBO’s at a glance. The Max streaming service has quietly launched a ...

We are under an ABC-7 First Alert in preparation for a gusty and dusty Tuesday in the Borderland. Today and tomorrow is looking nice! Today will have low-end winds and warm weather and tomorrow ...

I have been a technology journalist for 30-plus years and have covered just about every kind of computer gear—from the 386SX to 64-core processors—in my long tenure as an editor, a writer, and ...

With the best monitor with webcam, you get a quality display and a webcam camera in one single, streamlined design When you purchase through links on our site, we may earn an affiliate commission.

UI and web designer Dacia Petrie used her background in technology to create the Black Nile to fulfill the need and make it even easier for shoppers to buy Black-owned. The app currently features ...

Black poop can be harmless, caused by certain foods or medications, or it can be a sign of melena, meaning there’s blood in your stool. Melena happens when bleeding occurs in the upper digestive tract ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Black Diamond Therapeutics has found a partner for its deprioritized solid tumor candidate. Five months after cutting support for BDTX-4933, the biotech has licensed the RAF inhibitor to Servier ...

Servier will be responsible for the development and commercialization of BDTX-4933, a Phase I asset targeting solid tumors with RAS and RAF mutations. Black Diamond’s stock jumped more than 40% in pre ...

NEW YORK – Servier has signed a global licensing agreement with Black Diamond Therapeutics to develop and commercialize BDTX-4933 for treating RAF- and RAS-mutant solid tumors, including non-small ...